Counselors in Foster City, CA Accepting Medicare

4 Counselors found. Showing 1 - 4

Keely Murphy Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 672 Matsonia Dr, Foster City, CA 94404 Phone: 650-867-7024

Patrick Mehdi Mckinnie Counselor Medicare: Not Enrolled in Medicare Practice Location: 696 Saturn Ct, Foster City, CA 94404 Phone: 650-245-4748

Jason Pierce Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 815 Sea Spray Ln, #306, Foster City, CA 94404 Phone: 909-747-5117

Tonieh Chenoweth Counselor Medicare: Not Enrolled in Medicare Practice Location: 306 Bluefish Ct, Foster City, CA 94404 Phone: 650-759-0894

News Archive

Mass spectrometry can help visualize how drugs work inside living cells to kill infectious microbes

Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to "see" for the first time exactly how drugs work inside living cells to kill infectious microbes.

TOAST classification remains effective, easy-to-use system to classify strokes

In 1993, neurologists Harold P. Adams Jr., MD, and Jose Biller, MD, and colleagues proposed a new way to classify strokes. It became known as the TOAST classification. Twenty-two years later, the TOAST classification remains an effective and easy-to-use system that is routinely employed in stroke studies around the world, Drs. Adams and Biller report in the journal Stroke, published online ahead of print.

Researchers have uncovered evidence of sexual reproduction in a single-celled organism long thought to reproduce asexually

The finding by John M. Logsdon, Jr., assistant professor in the UI College of Liberal Arts and Sciences Department of Biological Sciences and the Roy J. Carver Center for Comparative Genomics, and colleagues from the UI and Roanoke College (Virginia), provides the first clear evidence that meiosis arose very early in eukaryotic evolution, bringing science one step closer to understanding the mystery of sexual evolution.

IBI initiates Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090

Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it has initiated its Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090 in patients undergoing cataract surgery.

Read more Medical News

› Verified 2 days ago